Naloxone buccal film - Klaria

Drug Profile

Naloxone buccal film - Klaria

Alternative Names: KL-00514

Latest Information Update: 14 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Klaria AB
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Opioid abuse

Most Recent Events

  • 14 Sep 2017 Chemical structure information added
  • 09 Aug 2017 Klaria and Purdue Pharma enter into an agreement to develop Naloxone buccal film for opioid abuse
  • 09 Aug 2017 Early research in Opioid abuse in Sweden (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top